About | Free Trial

Last Update

2016-04-03T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Pipasha Biswas?

Dr. Pipasha Biswas

Executive Director and QPPV

Symogen Limited

Direct Phone: +44 **********       

Symogen Limited

33 Wood Avenue South

Metropark, New Jersey 08830

United States

Company Description

Symogen is a niche service provider for all aspects of Pharmacovigilance, Pharmacoepidemiology, Medical Writing & Regulatory Services. Established in 2007, our clients are large and midsize pharmaceutical and biotech companies. Symogen Limited is 9001:2 ... more

Find other employees at this company (27)

Background Information

Affiliations

Chairperson, Special Interest Network Consultation Committee for Drug Safety and Pharmacovigilance, Faculty of Pharmaceutical Medicine
Royal College of Physicians

Member
International Society for Pharmacoepidemiology

Member
British Association of Regulatory and Quality Assurance

Member
ISoP Secretariat Ltd

Education

MD MFPM DM MRQA

Web References (47 Total References)


Dr Pipasha Biswas Executive ...

www.symogenlimited.com [cached]

Dr Pipasha Biswas Executive Director & QPPV

...
Dr Pipasha Biswas - Executive Director & QPPV
Dr. Pipasha Biswas is currently Principal Consultant, Director & QPPV of Symogen Ltd. She has been involved in pharmacovigilance & pharmacoepidemiology for the last 18 years in Europe, USA and India.
Dr. Pipasha Biswas has worked in a number of MNCs in Pharmacovigilance as Executive Director and Lead for Safety Signal detection at Global Drug Safety at Amgen Inc based in California, where she lead the safety signal detection team in global safety. In the UK, she worked as Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance at GSK, London, where she was the lead physician responsible for Respiratory and Anti-inflammatory therapeutic area. Prior to working at GSK, she was EU Senior Pharmacovigilance Physician at the European Office of Global Safety Surveillance and Epidemiology at Wyeth Europa, based in the UK. Before moving to the pharmaceutical industry, she was Clinical Research Fellow at the Drug Safety Research Unit, based in Southampton, where she conducted large studies in post marketing surveillance.
She also has considerable experience in Clinical Research and Clinical Drug Development, having worked at the Department of Vascular Medicine, King's College of Medicine & Dentistry, where she was responsible for conducting clinical trials in Deep Vein Thrombosis patients from phase II to III.
She qualified in Medicine from India and trained in Internal Medicine & Cardiology and did her post graduation in Pharmaceutical Medicine, from University of Surrey, UK. She then specialized in Pharmacovigilance & Pharmacoepidemiology from London School of Hygiene and Tropical Medicine, London and then did her DM in Pharmacoepidemiology from University of Southampton, UK. She is the Member of British Association of Research and Quality Assurance (BARQA), International Society of Pharmacovigilance (ISOP) and International Society of Pharmacoepidemiology (ISPE). She has been conferred with the Membership of The Faculty of Pharmaceutical Medicine (Distinction), UK from The Faculty of Pharmaceutical Medicine, The Royal College of Physicians, London. She is the member of the International Committee and Professional Standards Committee at the Faculty of Pharmaceutical Medicine of The Royal College of Physicians, London.


Dr. Pipasha Biswas, ...

www.symogenlimited.com [cached]

Dr. Pipasha Biswas, Executive Director and QPPV, SYMOGEN Limited speaking on From Signal management to Product Labelling at World Drug Safety Congress 2015 at Chicago.

Symogen DIA May
...
Dr. Pipasha Biswas Executive Director & QPPV will be Chairing and speaking on "Cause & Effect - Striving Towards Proactive Surveillance Through Innovation" at the 4th Pharmacovigilance, Drug Safety & Risk Management Conference 11-12 May 2015 at Holiday Inn Regents Park Hotel, London.
...
Dr. Pipasha Biswas, Signal Management to Preparation of Product Labels at the World Drug Safety Congress America 2015
SYMOGEN, one of the world's leading pharmacovigilance service providers is pleased to announce that Dr. Pipasha Biswas, Executive Director at SYMOGEN, will speak Signal Management to Preparation of Product Labels at the World Drug Safety Congress America 2015, 22-23 April.


New Outsourcing Frontier in India – Encore India Blog

encoreindia.com [cached]

"You need a lot of attention to detail to do this work," said Pipasha Biswas, director of Symogen Ltd. a U.K.-based pharmacovigilance consultancy.

...
Failing to meet deadlines is the most common way pharmaceutical companies fall short of pharmacovigilance requirements, said Dr. Biswas, the drug-safety consultant.


Pipasha ...

www.virtueinsight.com [cached]

Pipasha Biswas

...
PIPASHA BISWAS, Director, Symogen
...
PIPASHA BISWAS, Director, Symogen
...
Pipasha Biswas
Director
Symogen
Dr. Pipasha Biswas is currently Executive Director & QPPV of Symogen Ltd, UK, an international service provider in Pharmacovigilance, Pharmacoepidemiology, Medical Writing and Regulatory Affairs worldwide. She has been involved in pharmacovigilance for the last 20 years in Europe, USA and India. She has worked in a number of MNCs in Pharmacovigilance as Executive Medical Director and Lead for Safety Signal detection at Global Drug Safety at Amgen Inc based in California, where she lead the safety signal detection team in global safety. In the UK, she worked as Medical Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance at GSK, where she was the lead physician responsible for Respiratory and Antiinflammatory therapeutic area. Prior to working at GSK, London, she was EU Senior Pharmacovigilance Physician at the European Office of Global Safety Surveillance and Epidemiology at Wyeth Europa, based in the UK. Before moving to the pharmaceutical industry, she was Clinical Research Fellow at the Drug Safety Research Unit, based in Southampton, where she conducted large studies in post marketing surveillance,pharmacoepidemiology and signal detection activities.
She also has considerable experience in Clinical Research and Clinical Drug Development, having worked at the Department of Vascular Medicine, King's College of Medicine & Dentistry, where she was responsible for conducting clinical trials in Deep Vein Thrombosis patients from phase II to III.
She qualified in Medicine from India and trained in Internal Medicine & Cardiology and did her post graduation in Pharmaceutical Medicine, from University of Surrey, UK. She then specialized in Pharmacovigilance & Pharmacoepidemiology from London School of Hygiene and Tropical Medicine, London and then did her MD in Medicine and DM in Pharmacoepidemiology from University of Southampton, UK.
She is the Member of British Association of Regulatory and Quality Assurance (BARQA), International Society of Pharmacovigilance (ISOP) and International Society of Pharmacoepidemiology (ISPE). She has been conferred with the Membership of The
...
Pipasha Biswas, Symogen


Symogen - Pharmacovigilance Company, Services and Outsourcing

www.symogenlimited.com [cached]

and high quality of work under the leadership of Dr Pipasha Biswas.

...
Dr. Pipasha Biswas, Executive Director and QPPV, SYMOGEN Limited speaking on From Signal management to Product Labelling at World Drug Safety Congress 2015 at Chicago.
...
Lucky draw winner Dr. Mariette Boerstoel, Head Global Drug Safety and Pharmacovigilance Baxter, receiving the bottle of Moët & Chandon Rosé Impérial Champagne from Dr. Pipasha Biswas, Executive Director and QPPV, SYMOGEN Limited at World Drug Safety Congress 2015 at Chicago.
...
Dr. Pipasha Biswas Executive Director & QPPV will be Chairing and speaking on "Cause & Effect - Striving Towards Proactive Surveillance Through Innovation" at the 4th Pharmacovigilance, Drug Safety & Risk Management Conference 11-12 May 2015 at Holiday Inn Regents Park Hotel, London.
...
Dr. Pipasha Biswas, Signal Management to Preparation of Product Labels at the World Drug Safety Congress America 2015 SYMOGEN, one of the world's leading pharmacovigilance service providers is pleased to announce that Dr. Pipasha Biswas, Executive Director at SYMOGEN, will speak Signal Management to Preparation of Product Labels at the World Drug Safety Congress America 2015, 22-23 April.
...
Dr. Pipasha Biswas Signal Management to Preparation of Product Labels

Similar Profiles

Other People with this Name

Other people with the name Biswas

Shyamasri Biswas
University of Florida

P. Biswas

Satyaki Biswas
CIIGBC

Sumit Biswas
VOLTECH GROUP

Lopamudra Biswas
RBL Bank Ltd

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory